Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05089_nanopub.RAlF-eqkD-pRW7Fq-C4IFDJFJeA-V0hidn18qUoXVxA5Y#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05089 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05089 label "VPM4001 [drugbank:DB05089]" assertion.
- drugbank:DB05089 seeAlso DB05089 assertion.
- drugbank:DB05089 description "VPM4001 is an allogeneic vaccine for treatment of prostate carcinoma. It consists of irradiated human LNCaP cells that have been genetically modified to permanently secrete interferon-γ and interleukin-2 (LNCaP/IL-2/IFN-γ). Interferon-γ enhances presentation of tumour antigens, whereas interleukin-2 stimulates T cells." assertion.
- drugbank:DB05089 identifier "drugbank:DB05089" assertion.
- drugbank:DB05089 title "VPM4001" assertion.
- drugbank:DB05089 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05089 drugbank_vocabulary:drugbank-id "DB05089" assertion.
- drugbank:DB05089 bio2rdf_vocabulary:x-identifiers.org DB05089 assertion.
- drugbank:DB05089 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05089" assertion.
- drugbank:DB05089 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05089 bio2rdf_vocabulary:identifier "DB05089" assertion.